By a News Reporter-Staff News Editor at Life Science Weekly A patent application by the inventor Steiness, Eva, filed on February 10, 2014, was made available online on July 10, 2014, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Zealand Pharma A/s. See Holst, J J C
WASHINGTON- Actavis plc announced that the New Drug Application for Levosert, an investigational hormonal intrauterine contraceptive for use by women to prevent pregnancy, has been accepted for review by FDA. Actavis signed a partnership deal with Medicines360, a non-profit pharmaceutical company, for Levosert in June 2013. Anacor Pharmaceuticals I
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, has entered into a clinical trial collaboration with MedImmune, the global biologics research and development arm of AstraZeneca. The Phase I/II immunotherapy study will evaluate the safety and efficacy of MedImmune's investigational anti-PD-L1 immune...
ENP Newswire- 22 July 2014. Release date- 21072014- NEW YORK- Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's disease, other diseases of the central nervous system and various types of cancer, today announced that it has secured cGMP manufacturing of ANAVEX 2-73 for its dr
Anthera Pharmaceuticals said that it has purchased Sollpura, a novel investigational Pancreatic Enzyme Replacement Therapy from Eli Lilly and Company. EPI is estimated to afflict more than 150,000 patients in the United States alone, with more than US $600 million spent on enzyme replacement therapy annually. Anthera intends to sublicense all right
ALEXANDRIA, Va., July 22 Auspex Pharmaceuticals, Vista, California, has been assigned a patent developed by Chengzhi Zhang, San Diego, for a "biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor." The patent application was filed on April 9, 2010. Written by Vessie Ann Abalos.
Clinverse, Inc., provider of the first end-to-end technology solution for automating the financial lifecycle of global clinical trials, announced the addition of Shaun Williams as Vice President, Operations and the promotion of Heather Schultz to the newly created role of Senior Vice President, Product Solutions. He brings more than 20 years of exp
ERYTECH Pharma, the French biopharmaceutical company that develops innovative tumor starvation treatments for acute leukemia and other oncology indications with unmet medical needs, announces the enrollment of the first patient in its Phase I/II study with ERY-ASP in Acute Lymphoblastic Leukemia in the United States of America.. ERY-ASP, in E
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application and granted Priority Review for Avastin plus chemotherapy for the treatment of women with recurrent platinum-resistant ovarian cancer. New treatment options are needed, said S
Automated cell culture systems are instruments that mechanically support the growth and maintenance of cell culture. They allow production of optimum cells at a large scale to meet the needs of researchers in drug discovery and industries and biopharmaceutical companies. Established biopharmaceutical companies, such as Roche, Novo Nordisk, and Merc
InterMune reported that pirfenidone has been granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration. In a release, the Company noted that in May, InterMune resubmitted its New Drug Application for pirfenidone and noted a target FDA review of six months under the Prescription Drug User Fee Act. "The Breakthrough Therapy
ALEXANDRIA, Va., July 22 Isis Pharmaceuticals, Carlsbad, California, has been assigned a patent developed by three co-inventors for a "base modified bicyclic nucleosides and oligomeric compounds prepared therefrom." The co-inventors are Balkrishen Bhat, Carlsbad, California, Eric E. Swayze, Encinitas, California, and Charles Allerson, San Diego.
ALEXANDRIA, Va., July 22 Isis Pharmaceuticals, Carlsbad, California, has been assigned a patent developed by four co-inventors for a "modulation of eIF4E-BP1 expression." The co-inventors are Sanjay Bhanot, Carlsbad, California, Ravi Jain, Carlsbad, California, Kenneth W. Dobie, Del Mar, California, and Brett P. Monia, Encinitas, California. Writ
Dublin- Research and Markets has announced the addition of the "Licensing Terms and Agreements in Pharma, Biotech and Diagnostics" report to their offering. The Licensing Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by
Market Research Reports, Inc. has announced the addition of "Latest Guidebook for Conducting Pharma Clinical Trials in China: From Regulations to Practice" research report to their website http://www.marketresearchreports.com. China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest health
Merz North America will establish its headquarters in Raleigh, North Carolina, officials announced at a press conference with Gov. According to a release, the global pharmaceutical company- part of the Merz Pharma Group, with affiliates in 18 countries around the world- will move operations from current headquarters in Greensboro and from elsewhere
Dublin- Research and Markets has announced the addition of the "Partnering Agreements with Sun Pharmaceutical 2009-2014" company profile to their offering. The Partnering Agreements with Sun pharmaceutical 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.
By a News Reporter-Staff News Editor at Life Science Weekly According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Seehra, Jasbir; Knopf, John, filed on April 9, 2012, was published online on July 8, 2014. The assignee for this patent, patent number 8772234, is Acceleron Pharma, Inc..
By a News Reporter-Staff News Editor at Life Science Weekly A patent by the inventors Tsuruta, Kazuhisa; Aoki, Yoshikazu; Osawa, Yutaka; Kaul, Inder, filed on November 14, 2012, was published online on July 8, 2014, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 8772239 is assigned to As
Patent Issued for Method for the Preparation of a Silicic Acid Comprising Extrudate, Said Extrudate, Its Use and a Pharmaceutical Composition Comprising the Said Extrudate. By a News Reporter-Staff News Editor at Life Science Weekly A patent by the inventor Vanden Berghe, Dirk Andre Richard, filed on August 12, 2003, was published online on July
By a News Reporter-Staff News Editor at Cancer Weekly According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Guy, Geoffrey; Robson, Philip, filed on April 26, 2011, was published online on July 8, 2014. The assignee for this patent, patent number 8771760, is GW Pharma Limited. Reporters
By a News Reporter-Staff News Editor at Life Science Weekly From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Chan, Sham-Yuen; Tang, Hsinyi Yvette; Tao, Yiwen; Wu, Yongjian; Kelly, Ruth, filed on March 13, 2013, was published online on July 8, 2014. The patent's assignee for patent number 8772027 is Bayer Pharmac
ALEXANDRIA, Va., July 22 Quark Pharmaceuticals, Fremont, California, has been assigned a patent developed by four co-inventors for methods and compositions "for treating diseases, disorders or injury of the CNS." The co-inventors are Igor Spivak, Haifa, Israel, Evgenia Alpert, Jerusalem, Israel, Ron Lahav, Kibbutz, Israel, and Elena Feinstein, Re
Salix Pharmaceuticals and Pharming Group NV reported that the Food and Drug Administration has approved Ruconest 50 IU/kg for the treatment of acute angioedema attacks in adult and adolescent patients with hereditary angioedema. "We are pleased that Ruconest provides the HAE community with another FDA- approved option for treating painful and...
By a News Reporter-Staff News Editor at AIDS Weekly A patent application by the inventors XIE, Dong; JIANG, He, filed on June 25, 2013, was made available online on July 10, 2014, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Baobab Pharmaceuticals Limited. The foll